Clinical Trial Update: Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating tocilizumab for prevention of graft failure and graft-versus-host disease in haplo-cord transplantation; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Hematologic Malignancy, Bone Marrow Transplant | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-23